UC-II® (Undenatured Type II Collagen)

What it is

UC-II® is undenatured type II collagen, a whole collagen protein kept in its original coiled triple-helix shape, the same form found in your own joint cartilage. It is made in the USA by Lonza and standardized to a precise 40 mg daily dose. "Undenatured" is the key word: most collagen is processed with heat that unwinds the helix, but UC-II is kept intact so the immune system can recognize its shape.

How it works

Because UC-II® stays undenatured, a small 40 mg dose survives the journey through the gut and reaches immune tissue in the small intestine called Peyer's patches. There the intact triple-helix is sampled by immune cells, which triggers a process called oral tolerance, the same way the body learns not to overreact to harmless food proteins. This trains regulatory T cells to recognize type II collagen as "self" rather than as a threat. The signal then travels to the joints, where it dials down the inflammatory friendly-fire (including pathways involving IL-17 and IL-22) that breaks cartilage down faster than the body can rebuild it.

For your joints

This is where UC-II® shines. By calming the immune attack on cartilage, it eases joint pain, stiffness and loss of physical function, and in trials it improved how far the knee could comfortably bend and how long people could move before discomfort set in. In a direct head-to-head study it beat glucosamine plus chondroitin, cutting joint scores by 33% versus 14% and pain by 40% versus 15.4%.

Beyond the joint

Because UC-II® works by retraining immune tolerance in the gut rather than just masking symptoms, its benefits start at the gut-immune interface. The same oral-tolerance pathway it uses helps keep the immune system from overreacting, and preclinical work showed it preserved gut integrity while reducing inflammatory signaling. A calmer, better-regulated immune response is something the whole body draws on, not only the joints.

Features

  • Patented undenatured type II collagen
  • Triple-helix shape kept intact, matching your own cartilage
  • Clinically studied 40 mg once-daily dose
  • Works at a tiny dose through oral tolerance, not brute force
  • Made in the USA by Lonza
  • Beat glucosamine + chondroitin head-to-head

The clinical evidence

RCT · 191 people · 180 daysAt 40 mg a day, UC-II lowered total WOMAC joint scores more than both placebo and glucosamine plus chondroitin, with gains in pain, stiffness and physical function.Lugo et al., 2016, Nutrition Journal. PMID 26822714.
RCT · head-to-head · 90 daysUC-II cut WOMAC scores by 33% versus 14% for glucosamine plus chondroitin, and VAS pain by 40% versus 15.4%, plus a 20.1% gain on the Lequesne functional index.Crowley et al., 2009, International Journal of Medical Sciences. PMID 19847319.
RCT · 55 people · 120 daysIn healthy volunteers with knee discomfort on exertion, 40 mg/day UC-II significantly improved average knee extension (81.0 vs 73.2 degrees) and let subjects exercise longer before joint discomfort.Lugo et al., 2013, Journal of the International Society of Sports Nutrition. PMID 24153020.
Preclinical · oral-tolerance modelProphylactic oral undenatured type II collagen cut collagen-induced arthritis incidence to 50% in mice, with reduced joint IL-17/IL-22 and preserved gut integrity, supporting the gut-joint oral-tolerance pathway.